NeuralNet Medical
NeuralNet Medical Raises $680M Series D to Revolutionize HealthTech
Quick Facts
NeuralNet Medical
AI-powered diagnostic platform using neural networks to detect cancer, neurological disorders, and rare diseases with 99.7% accuracy from medical imaging.
About the Funding
NeuralNet Medical has successfully raised $680M in a Series D funding round, bringing their total valuation to $9.4B. This significant investment will fuel the company's mission to expand fda approvals for additional conditions, scale ai model training, and deploy in 500+ hospitals globally.
Use of Funds
Expand FDA approvals for additional conditions, scale AI model training, and deploy in 500+ hospitals globally
Company Overview
AI-powered diagnostic platform using neural networks to detect cancer, neurological disorders, and rare diseases with 99.7% accuracy from medical imaging.
Market Opportunity
The healthtech market is experiencing unprecedented growth in 2025, with increasing demand for innovative solutions that ai-powered diagnostic platform using neural networks to detect cancer, neurological disorders, and rare diseases with 99.7% accuracy from medical imaging.. NeuralNet Medical is positioned to capture significant market share through their differentiated technology platform and strategic partnerships.
Key Investors
- • Johnson & Johnson Innovation
- • Google Health
- • Andreessen Horowitz
- • GV
Founders
- • Dr. Neural AI
- • Dr. Medical Vision
Previous Rounds
Investment Highlights
Technology Innovation
NeuralNet Medical has developed breakthrough technology that addresses key market challenges and provides significant competitive advantages in the healthtech space.
Market Traction
Strong customer adoption and revenue growth demonstrate market validation and scalability potential for NeuralNet Medical's innovative solutions.
Team Excellence
Led by experienced founders with deep domain expertise, NeuralNet Medical has assembled a world-class team capable of executing on ambitious growth plans.
Strategic Partnerships
Strong investor syndicate and strategic partnerships provide NeuralNet Medical with the resources and market access needed for global expansion.
Looking Forward
With this $680M investment, NeuralNet Medical is well-positioned to accelerate growth, expand market presence, and continue innovation in the healthtech sector. The funding will enable the company to achieve key milestones and establish market leadership while delivering exceptional value to customers and stakeholders.
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
